xconomy.com
Azigo, Dyn, Pathogenica, and Smarterer: Boston Startup News | Xconomy
http://www.xconomy.com/boston/2012/09/20/azigo-pathogenica-smarterer-and-more-boston-startup-news
Top Entrepreneurs’ Advice. All the information, none of the junk biotech healthcare life sciences. Want EXOME sent to you daily? Azigo, Dyn, Pathogenica, and Smarterer: Boston Startup News. Gregory T. Huang. September 20th, 2012. A quick look at what’s happening around the horn today:. A DNA-sequencing technology startup specializing in detecting pathogens, has formed an exclusive partnership with Life Technologies (NASDAQ: LIFE. 8212;New startup Azigo. 8212;New Hampshire-based Dyn. And continues to grow...
arep.med.harvard.edu
B1 GCLab
http://arep.med.harvard.edu/gmc/B1.html
This goes far beyond quantitating species in a microbiome. This includes functional microbiomics (2008, 2010), immune response to vaccines (2014) and detecting the links between microbial immunity and automimmunity (2013). Perturbation can go beyond vaccines to engineering and selecting microbiomes (2013) and this includes our synthetic ecosystems. Research and and enhanced safety features. Method is systematically discovering Protein Motifs. Relevant Church Lab Publications.